v 17 statistical software package (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
v 17 statistical software package
V 17 Statistical Software Package, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36628 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+17+statistical+software+package/STATA+1%2E0/pmc12397398-142-7-6
Average 99 stars, based on 36628 article reviews
V 17 Statistical Software Package, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36628 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+17+statistical+software+package/STATA+1%2E0/pmc12397398-142-7-6
Average 99 stars, based on 36628 article reviews
v 17 statistical software package - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Software:Article Title: COVID-19 prevention behaviors are congruent within social networks of disenfranchised Hispanic and criminal legal involved community members Article Snippet: .. All analyses were performed using the STATA Article Title: Fulminant onset COVID-19: predictors and outcome Article Snippet: .. Statistical analysis was done using STATA Article Title: Effect of Dietary Phenolic Compounds on Incidence of Type 2 Diabetes in the "Seguimiento Universidad de Navarra" (SUN) Cohort. Article Snippet: .. Data analyses were performed with the Stata Article Title: A randomised controlled trial of a Multidisciplinary TEAM-based approach to guide secondary risk prevention for cardiovascular and limb outcomes in patients with Peripheral Artery Disease (TEAM-PAD) study protocol. Article Snippet: Background: Peripheral arterial disease (1) is a vascular condition associated with significant cardiovascular morbidity and mortality.. Effective secondary prevention strategies are essential to improve cardiovascular outcomes in patients with PAD.. The TEAM-PAD study aims to determine if a centralised virtual multidisciplinary team (MDT) model of care is effective in improving guideline-recommended secondary cardiovascular risk reduction for outpatients with PAD. Article Title: Accelerated neuropathy among chronic kidney disease patients undergoing hemodialysis: Analysis of an institutional cluster. Article Snippet: Correspondence Subrahmanian Sathiavageesan, Department of Nephrology, Sundaram Hospital, 17, EVR Road, Puthur, Trichy, Tamil Nadu 620017, India.. Email: spssubrahmanian@yahoo.co.in Abstract Background: Accelerated neuropathy is a rare syndrome of rapidly worsening peripheral neuropathy, typically described in end-stage kidney disease (ESKD) patients undergoing dialysis.. In our center, we encountered a surge in the occurrence of accelerated neuropathy among ESKD patients undergoing hemodialysis, which prompted systematic research. Article Title: Effect of Dietary Phenolic Compounds on Incidence of Type 2 Diabetes in the “Seguimiento Universidad de Navarra” (SUN) Cohort Article Snippet: .. Data analyses were performed with the Stata Two Tailed Test:Article Title: A randomised controlled trial of a Multidisciplinary TEAM-based approach to guide secondary risk prevention for cardiovascular and limb outcomes in patients with Peripheral Artery Disease (TEAM-PAD) study protocol. Article Snippet: Background: Peripheral arterial disease (1) is a vascular condition associated with significant cardiovascular morbidity and mortality.. Effective secondary prevention strategies are essential to improve cardiovascular outcomes in patients with PAD.. The TEAM-PAD study aims to determine if a centralised virtual multidisciplinary team (MDT) model of care is effective in improving guideline-recommended secondary cardiovascular risk reduction for outpatients with PAD. |